Trials / Unknown
UnknownNCT01334684
Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes
White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Casa Sollievo della Sofferenza IRCCS · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Our general aim is to investigate whether messenger RNA (mRNA) and/or microRNA (miRNA) expression profiles in white blood cells, predict metformin monotherapy efficacy in patients with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Metformin, pills, 850 mg three times a day for three months |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-04-01
- Completion
- 2013-09-01
- First posted
- 2011-04-13
- Last updated
- 2011-04-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01334684. Inclusion in this directory is not an endorsement.